Canica

Canica is a prominent privately owned investment company based in Oslo, Norway, founded in 1985. The firm specializes in active, long-term ownership across various sectors, including retail, fast-moving consumer goods, financial investments, and real estate. Canica leverages its expertise in business development and finance to create value and foster employment over the long term. By focusing on branded consumer goods and services, along with strategic investments in real estate, Canica aims to enhance its portfolio and contribute to sustainable business growth.

Nils Kloumann Selte

CEO

Jan Ole Stangeland

CFO

Past deals in Norway

Cytovation

Series A in 2022
Cytovation AS, a biotechnology company, develops peptide products for the treatment of cutaneous warts caused by human papilloma virus (HPV). The company's product CyPep-1 consists of 27 amino acids, targets HPV diseased cells, and kills the wart cells by disrupting the cell membrane and creating an immune response through the release of antigens. CyPep-1 has world-wide patent protection across the USA, Europe, Japan, and China. The company was founded in 2001 and is based in Bergen, Norway.

Oncoinvent

Venture Round in 2021
Oncoinvent AS develops antibody based therapeutics for cancer patients. It offers Radspherin, an alpha-emitting radioactive microsphere designed for treatment of metastatic cancers in body cavities; radiotherapeuti; radioimmunotherapeutic; and immunotherapeutic products. The company was founded in 2010 and is based in Oslo, Norway.

Porterbuddy

Corporate Round in 2019
They are the gang that delivers to your door the same day you order in the online store.Porterbuddy'​ is a logistics platform that provides efficient and customer-centric, last-mile delivery of products.

SixBondStreet AS

Private Equity Round in 2019
Sixbondstreet is an online retailer of exclusive furniture and decorative items.sixbondstreet with international impulses and a desire to deliver the little extra in furniture and interior design.

Blush

Private Equity Round in 2019
Blush is an online retailer based in Vaxjo, Sweden, specializing in beauty and wellness products. The company offers a wide range of items, including makeup, skin creams, hair care products, perfumes, and accessories such as sunglasses and watches. Blush features both established brands and exciting newcomers, catering to customers seeking quality at affordable prices. As a prominent player in Norway's beauty and wellness market, Blush aims to provide a convenient shopping experience for those looking to pamper themselves and enhance their personal care routines.

Farmasiet

Private Equity Round in 2019
Farmasiet is Norway's largest online pharmacy delivering to the entire country. We also have a physical pharmacy in Sandefjord.

Bildeler

Private Equity Round in 2019
Bildeler.no operates an online retailer of auto parts. The company’s store, sales and procurement are located at Lierskogen, between Drammen and Oslo. After the transaction, Verdane and Canica will together own 90 percent of Bildeler.no

Skitude

Series A in 2019
Skitude Holding AS provides digital and mobile platforms for the monitoring, gamification, and sharing of skiing, snowboarding, and other outdoor activity experiences. It connects skiers and outdoor enthusiasts with mountain resorts through a range of smartphone apps, access to ski resorts through Skitude Instant Access, and the purchase of ski passes and other ski resort services. The company was founded in 2016 and is headquartered in Oslo, Norway.

Arundo Analytics

Series A in 2018
Arundo Analytics, Inc. develops analytics products that analyze data from the client’s assets and predicts the likely failures to enhance their operations. The company’s analytics solutions allow clients to make operational and maintenance decisions. It primarily services asset intensive industries with big data and machine learning products in the United States. The company was incorporated in 2015 and is based in Houston, Texas with additional offices in Palo Alto, California; Oslo, Norway; Stockholm, Sweden; and London, United Kingdom.

Oncoinvent

Venture Round in 2017
Oncoinvent AS develops antibody based therapeutics for cancer patients. It offers Radspherin, an alpha-emitting radioactive microsphere designed for treatment of metastatic cancers in body cavities; radiotherapeuti; radioimmunotherapeutic; and immunotherapeutic products. The company was founded in 2010 and is based in Oslo, Norway.